DiaSorin has obtained FDA Emergency Use Authorization for its LIAISON® SARS-CoV-2 Ag for COVID-19 testing in the U.S.

Protocollo

92974

Comunicato

Azienda

DIASORIN

Tipo

Comunicato

SDIR

SDIRNIS

Lingua

ENG

Data creazione

Mon, 03/29/2021 - 09:02

Data ricezione SDIR

Mon, 03/29/2021 - 09:01

Data embargo SDIR

Mon, 03/29/2021 - 09:01

Data diffusione SDIR

Mon, 03/29/2021 - 09:02

Mercato

Euronext Milan